The recently proposed new classification and intervention for hypertension published
by the ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Panel [
[1]
] have caused lots of controversy since it lowers the cut-off value from 140/90 to
130/80 mm Hg to initiate a pharmacological intervention. This guideline focuses on
the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults,
however, the main controversy lies on recommending a pharmacological intervention
to patients reaching 140/90 mm Hg and people with 130/80 mm Hg and cardiovascular
risk higher than 10%. This decision was supported in multiple studies describing an
increased risk of coronary, stroke events, renal and other end-point organs damage,
as the pressure rises.- Whelton P.K.
- Carey R.M.
- Aronow W.S.
- Casey D.E.
- Collins K.J.
- Dennison Himmelfarb C.
- et al.
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection,
evaluation, and management of high blood pressure in adults: executive summary.
Hypertension. 2017; 2017 (doi:10.1161/HYP.0000000000000066): e00
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary.Hypertension. 2017; 2017 (doi:10.1161/HYP.0000000000000066): e00
- A randomized trial of intensive versus standard blood-pressure control.N Engl J Med. 2015; 373: 2103-2116https://doi.org/10.1056/NEJMoa1511939
- Blood-pressure lowering in intermediate-risk persons without cardiovascular disease.N Engl J Med. 2016; 374: 2009-2020https://doi.org/10.1056/NEJMoa1600175
- Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels.JAMA Intern Med. 2018; 178: 28-36https://doi.org/10.1001/jamainternmed.2017.6015
- Epigenetic modifications in essential hypertension.Int J Mol Sci. 2016; 17: 451https://doi.org/10.3390/ijms17040451
Article info
Publication history
Published online: January 15, 2018
Accepted:
January 11,
2018
Received in revised form:
January 10,
2018
Received:
January 5,
2018
Identification
Copyright
© 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
